Altre lingue Agenus Inc.

Azioni

AGEN

US00847G8042

Tempo reale stimato Cboe BZX Altri mercati azionari 19:50:16 26/04/2024			Variaz. 5gg	Var. 1 gen.
11,14 ^USD	+34,28%		+106,40%	-33,81%

12/04	Aggiornamento settoriale: titoli del settore sanitario in calo nel tardo pomeriggio	MT
12/04	Aggiornamento settoriale: Assistenza sanitaria	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Agenus Inc. - Botensilimab, Balstilimab Data in MSS CRC Selected for the American Society of Clinical Oncology 2024 Annual Meeting	25/04
Botensilimab/Balstilimab Data in MSS CRC Selected for the American Society of Clinical Oncology 2024 Annual Meeting	24/04
Agenus to Provide First Quarter 2024 Financial Report and Corporate Update	23/04
Agenus Announces Updated Phase 1 Data and Progress on BOT/BAL Development in Metastatic MSS Colorectal Cancer	15/04
Sector Update: Health Care Stocks Slipping Late Afternoon	12/04
Sector Update: Health Care	12/04
Agenus Shares Decline After Update on Early Stage Colorectal Cancer Drug Trial	12/04
Agenus Announces Updated Phase 1 Data and Progress on BOT/BAL Development in Metastatic MSS Colorectal Cancer	12/04
Agenus Announces Updated Phase 1 Data and Progress on BOT/BAL Development in Metastatic MSS Colorectal Cancer	12/04
Agenus Stockholders Approve 1-for-20 Reverse Stock Split	05/04
Agenus Announces Reverse Stock Split of Common Stock	05/04
Agenus : Submission of Matters to a Vote of Security Holders - Form 8-K	05/04
Earnings Flash (AGEN) AGENUS Posts Q4 Revenue $83.8M	14/03
Agenus: Q4 Earnings Snapshot	14/03
Agenus Reports Fourth Quarter and Full Year 2023 Results	14/03
Agenus Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	14/03
Agenus Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	14/03
Agenus Announces Preclinical Data on BMS-986442 at AACR 2024	07/03
Agenus Reports Inducement Grants under Nasdaq Listing Rule 5635(4)	06/03
Agenus Announces Preclinical Data on BMS-986442 (AGEN1777) at AACR 2024	06/03

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Agenus Inc.

Azioni

AGEN

US00847G8042

Altre lingue

Filtri